Bioartificial organ-based device developer Innovative Biotherapies won $1.6 million from the FDA through a grant to boost the development of products for patients with rare diseases, according to the federal watchdog. The $1.6 million, distributed over 4 years, will aid Innovative Biotherapies in a Phase 2 study of selective cytopheretic device for the treatment of […]